ARCHIVES

SEC Notifies ImClone It May Bring Action Against Company

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

Increased Lung Cancer Risk After Hodgkin’s Treatment

February 22, 2002

In Brief: Moffitt Gets $100M From Fla. For Construction; Two Head And Neck Surgical Societies Merge

July 3, 1998

NPCC Workshop Developed “Exciting List” Of Projects, Organizer Says

November 8, 1996

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

Phase III Xilonix Study Halted Following Unscheduled Analysis

September 26, 2014

Cytopathologists, NCI Recommend New Method For Pap Smear Reports

August 25, 1989